fbpx

ESPI Current Report, No. 1/2023, Acquisition of a production line for nutraceuticals and dietary supplements in liquid form. MEDIAN POLSKA S.A. (PLMDNPL00013)

09-01-2023 12:10:31 | Current | ESPI | 1/2023

Legal basis
Article 17 (1) MAR – confidential information.
Content of the report:

The Management Board of Median Polska S.A, announces that in connection with the acquisition of shares and competencies of Hempley Sp. z o.o. _EPSI Announcement 12/2022 dated August 26, 2022_, Median Polska S.A. on January 0, 2023, acquired and took delivery of an automated production line for nutraceuticals and dietary supplements in liquid form.

This investment will allow us to optimize costs and increase production capacity, which will translate into better quality and availability of our products. We are confident that this new production line will be a win-win for our company and our customers. In addition, this line, will enable us to introduce new products to the market.

The Management Board of the Issuer provides this information due to the fact that the purchase of the machine and the subsequent sale of products may affect the Issuer’s financial results.

  • Piotr Zawadzki- President of the Management Board

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top